{
  "run_date": "2026-02-07T19:24:31.290261+00:00",
  "stocks_scanned": 235,
  "top_picks": [
    {
      "ticker": "TKA",
      "name": "thyssenkrupp AG",
      "exchange": "XETR",
      "index": "DAX",
      "sector": "Industrials",
      "price": 11.655,
      "currency": "EUR",
      "market_cap": 9659455488,
      "pe_ratio": 15.54,
      "forward_pe": 10.92704,
      "roe": 5.0869998,
      "dividend_yield": 129.0,
      "momentum_6m": 19.602403566203286,
      "momentum_12m": 157.50894348275168,
      "rsi_14": 66.40772694967322,
      "alpha_score": 82,
      "score_breakdown": {
        "value": 21,
        "quality": 15,
        "momentum": 25,
        "catalyst": 13,
        "liquidity": 8
      },
      "yahoo_url": "https://finance.yahoo.com/quote/TKA.DE",
      "signal": "HOLD",
      "confidence": "HIGH",
      "reasoning": "thyssenkrupp demonstrates positive momentum from earnings growth (26% annual average) and strong recent returns, with improving projections for EBITDA and net income in 2026, but lacks fresh operational catalysts in the immediate term amid reporting blackouts.[4][5][6] Valuation at P/E 15.5 and ROE 5.1% appears reasonable given industrials sector pressures, though global macroeconomic headwinds temper upside without Q1 confirmation.[1][2] High alpha score (82/100, driven by momentum and value) supports holding, but limited visibility warrants caution ahead of February earnings.",
      "company_overview": "thyssenkrupp AG is a diversified German industrial conglomerate focused on steel, automotive components, engineering, and materials, operating in a challenging macroeconomic environment while continuing its transformation process.[2] The company maintains a solid market position in Europe with segments like steel production and marine systems, supported by recent strong stock performance (6m +19.6%, 12m +157.5%) and projected earnings growth outpacing the metals and mining industry.[5][6] Fiscal year 2025/2026 (starting October 1, 2025) shows improving profitability trends, with net income projected at 464.13 M EUR for 2026 and EBITDA rising significantly.[4][6]",
      "key_developments": [
        "Annual General Meeting held on January 30, 2026, marking key governance updates post-fiscal year end.[2]",
        "Ongoing closed period (January 13 to February 12, 2026) prohibiting insider trading, signaling preparation for Q1 results amid quiet period starting January 21.[1]",
        "No specific ad hoc releases or operational news detailed in the last 30 days (since early January 2026); focus remains on transformation continuation.[2]"
      ],
      "catalysts": [
        "Q1 2025/2026 interim report and analyst conference call on February 12, 2026, with CEO Miguel \u00c1ngel L\u00f3pez and CFO Dr. Axel Hamann, potentially revealing early fiscal momentum.[1][2][3]",
        "Release of detailed Q1 financial documents and conference call replay, offering insights into transformation progress and segment performance.[3]"
      ],
      "risk_factors": [
        "Challenging macroeconomic environment impacting industrial demand, particularly in steel and engineering segments during ongoing transformation.[2]",
        "Potential weak Q1 results or guidance downgrade, given closed/quiet periods limiting transparency until February 12.[1][3]"
      ],
      "sources": [
        "https://www.thyssenkrupp.com/en/investors/calendar",
        "https://www.thyssenkrupp.com/en/investors",
        "https://www.thyssenkrupp.com/en/investors/reporting-and-publications",
        "https://www.marketscreener.com/quote/stock/THYSSENKRUPP-AG-436698/finances/",
        "https://simplywall.st/stocks/de/materials/etr-tka/thyssenkrupp-shares/past",
        "https://eulerpool.com/en/stock/thyssenkrupp-Stock-DE0007500001/NetIncome"
      ],
      "target_timeframe": "3-6 months"
    },
    {
      "ticker": "EN",
      "name": "Bouygues SA",
      "exchange": "EPA",
      "index": "CAC40",
      "sector": "Industrials",
      "price": 48.25,
      "currency": "EUR",
      "market_cap": 18544437248,
      "pe_ratio": 17.545454,
      "forward_pe": 13.719469,
      "roe": 8.397,
      "dividend_yield": 415.00000000000006,
      "momentum_6m": 25.84767816372373,
      "momentum_12m": 60.73101046194995,
      "rsi_14": 69.28839450740628,
      "alpha_score": 78,
      "score_breakdown": {
        "value": 21,
        "quality": 9,
        "momentum": 25,
        "catalyst": 13,
        "liquidity": 10
      },
      "yahoo_url": "https://finance.yahoo.com/quote/EN.PA",
      "signal": "HOLD",
      "confidence": "LOW",
      "reasoning": "Limited recent news beyond routine share disclosures leaves the business trajectory stable but opaque, with strong historical returns (+60.7% 12m) and momentum (Alpha Score 78/100) offset by low-volume trading signals and no clear fundamental catalysts.[1] In a European industrials context, diversification across essential sectors supports resilience, but absence of updates amid global economic uncertainties warrants caution over the next 3-6 months.[2][3] Hold/accumulate aligns with technical forecasts of modest 3-month gains to $9.20-$9.86 (OTC basis).[1]",
      "company_overview": "Bouygues SA is a diversified French services group operating in over 80 countries with approximately 200,000 employees, spanning **construction** (Colas, Bouygues Construction, Bouygues Immobilier), **energies & services** (Equans), **telecoms** (Bouygues Telecom), and **media** (TF1).[2][3] The company maintains a stable share structure, with 385,439,418 shares and around 496-497 million voting rights as of January 31, 2026, reflecting no major changes in capitalization.[2][3] Its EPA-listed stock (EN) trades at \u20ac48.25, showing strong momentum with +25.8% 6-month and +60.7% 12-month returns, supported by a P/E of 17.5 and ROE of 8.4% amid a positive short-term trend.",
      "key_developments": [
        "Monthly disclosure on February 2, 2026, confirming total shares at 385,439,418 and exercisable voting rights at 496,550,003 as of January 31, 2026, available on the company's website under regulated information.[2][3]",
        "Stock price rose 0.364% on February 3, 2026 (last trading day referenced), from $10.98 to $11.02 (OTC equivalent BOUYY), within a weak rising short-term trend signaling potential +5.92% upside over 3 months.[1]",
        "No other major operational news or events reported in the last 30 days; technical indicators show buy signals from moving averages but a hold/accumulate rating due to low volume divergence risks.[1]"
      ],
      "catalysts": [
        "Potential Q4 2025 or early 2026 earnings release, which could highlight performance in construction, telecoms, or Equans amid European infrastructure spending.[2]",
        "Upcoming project wins or contract announcements in core segments like Bouygues Telecom or Colas, driving growth in changing energy and construction needs.[3]"
      ],
      "risk_factors": [
        "Low trading volume with price divergence, increasing short-term volatility and potential for trend reversal below supports at $8.91-$9.02 (OTC).[1]",
        "Broader industrials sector exposure to European economic slowdowns, rising material costs, or regulatory shifts in telecoms/media without recent positive disclosures.[2][3]"
      ],
      "sources": [
        "https://stockinvest.us/stock/BOUYY",
        "https://live.euronext.com/en/products/equities/company-news/2026-02-02-bouygues-monthly-disclosure-total-number-shares-and",
        "https://www.globenewswire.com/news-release/2026/02/02/3230458/0/en/bouygues-monthly-disclosure-of-the-total-number-of-shares-and-voting-rights.html",
        "https://ng.investing.com/equities/bouygues-n-historical-data"
      ],
      "target_timeframe": "3-6 months"
    },
    {
      "ticker": "AZN",
      "name": "AstraZeneca PLC",
      "exchange": "LSE",
      "index": "FTSE100",
      "sector": "Healthcare",
      "price": 14104.0,
      "currency": "GBP",
      "market_cap": 218651983872,
      "pe_ratio": 31.623316,
      "forward_pe": 18.560966,
      "roe": 21.674,
      "dividend_yield": 173.0,
      "momentum_6m": 27.799927509967382,
      "momentum_12m": 20.387470630408732,
      "rsi_14": 54.043839758125465,
      "alpha_score": 75,
      "score_breakdown": {
        "value": 5,
        "quality": 22,
        "momentum": 25,
        "catalyst": 13,
        "liquidity": 10
      },
      "yahoo_url": "https://finance.yahoo.com/quote/AZN.L",
      "signal": "BUY",
      "confidence": "MEDIUM",
      "reasoning": "AstraZeneca's NYSE listing enhances liquidity and US investor access, aligning with strong recent performance and long-term growth targets amid a favorable healthcare sector outlook.[1] Pipeline momentum and reiterated 2030 goals of $80B revenue signal sustained trajectory, though elevated P/E warrants monitoring for execution risks. Global harmonization positions AZN competitively in European and US markets.",
      "company_overview": "AstraZeneca PLC (AZN) is a global biopharmaceutical company focused on oncology, rare diseases, and bioPharmaceuticals, with a strong market position evidenced by recent robust growth and a harmonized global listing structure across NYSE, LSE, and Nasdaq Stockholm. The company trades ordinary shares under the AZN ticker on the NYSE as of recent filings, replacing prior American Depositary Shares, while maintaining its UK and Swedish listings unchanged.[1] Key metrics show a P/E of 31.6, ROE of 21.7%, and strong returns of +27.8% over 6 months and +20.4% over 12 months, reflecting positive momentum amid a current price of 14104.0 pence on LSE.",
      "key_developments": [
        "AstraZeneca commenced trading of ordinary shares on the NYSE under the AZN ticker, creating a harmonized global listing with LSE and Nasdaq Stockholm to access the world's largest capital market and broaden its investor base.[1]",
        "Management reiterated confidence in its 2030 ambition of $80 billion in annual revenue and launching 20 new medicines, supported by pipeline readouts representing over $10 billion in peak revenue opportunity.[1]",
        "Transition of US dollar bonds to NYSE trading alongside the ordinary shares, with no changes to UK/Swedish index memberships.[1]"
      ],
      "catalysts": [
        "Pipeline readouts from high-potential programs, potentially unlocking over $10B in peak revenue as highlighted by management.[1]",
        "Progress toward 2030 targets, including launches of new medicines, which could drive revenue acceleration and analyst upgrades."
      ],
      "risk_factors": [
        "Execution risks on ambitious 2030 revenue goal amid competitive biopharma landscape and regulatory hurdles.",
        "Potential volatility from pipeline setbacks or broader market pressures on high P/E healthcare stocks."
      ],
      "sources": [
        "https://www.stocktitan.net/sec-filings/AZN/6-k-astrazeneca-plc-current-report-foreign-issuer-5cf8521c5fa8.html"
      ],
      "target_timeframe": "3-6 months"
    },
    {
      "ticker": "FERG",
      "name": "Ferguson Enterprises Inc.",
      "exchange": "LSE",
      "index": "FTSE100",
      "sector": "Industrials",
      "price": 19170.0,
      "currency": "GBP",
      "market_cap": 38471598080,
      "pe_ratio": 26.260273,
      "forward_pe": 23.096275,
      "roe": 33.404,
      "dividend_yield": 138.0,
      "momentum_6m": 16.616244059754326,
      "momentum_12m": 31.685590830856224,
      "rsi_14": 64.28571428571428,
      "alpha_score": 71,
      "score_breakdown": {
        "value": 9,
        "quality": 22,
        "momentum": 25,
        "catalyst": 5,
        "liquidity": 10
      },
      "yahoo_url": "https://finance.yahoo.com/quote/FERG.L",
      "signal": "BUY",
      "confidence": "HIGH",
      "reasoning": "Ferguson's execution remains strong with margin expansion, double-digit non-residential growth, and a fortress balance sheet enabling acquisitions and $800M+ repurchase capacity, positioning it to capture multi-year U.S. infrastructure and housing tailwinds.[1][2][3][4] Residential headwinds appear temporary (soft housing starts, RMI), while diversification and pricing discipline support sustained outperformance versus peers in a volatile industrials sector.[3] At P/E 26.3 and ROE 33.4%, valuation reflects quality but offers upside if guidance is met.[1][3]",
      "company_overview": "Ferguson Enterprises Inc. (FERG) is a leading North American distributor of plumbing, HVAC, waterworks, and related products, primarily serving the U.S. (over 95% of sales) with a focus on residential and non-residential markets.[1][2][3] The company holds a strong market position through diversification, operational efficiency, and strategic acquisitions, evidenced by Q1 FY2026 (ended October 31, 2025) net sales of $8.2 billion (up 5.1% YoY), gross margin expansion to 30.7%, and adjusted operating profit of $808 million (up 14.4%).[1][2][3] Despite robust non-residential growth (12%), residential weakness offset some gains, leading to a post-earnings stock dip, though shares have delivered +31.7% over 12 months amid a solid balance sheet (net debt/EBITDA 1.1x).[3][4]",
      "key_developments": [
        "Reported Q1 FY2026 results on December 9, 2025: $8.2B sales (+5.1% YoY, 4.2% organic), adjusted EPS $2.84 (+15.9% YoY, beat consensus $2.64-$2.77 but missed some higher forecasts ~$2.97), with non-residential sales up 12% (Waterworks +14%, Commercial/Mechanical +21%) offsetting residential decline of 1%; stock fell ~3-4% premarket.[1][2][3][4][8]",
        "Acquired Moore Supply Company to bolster HVAC presence in Chicago; returned $372M to shareholders ($208M repurchases, 7% dividend hike to $0.89/share); strong cash flow ($325M free cash flow, +18.6% YoY).[1][2][4]",
        "Updated FY2025 guidance: ~5% revenue growth, operating margins 9.4-9.6% (improved from prior 9.2-9.6%), CapEx ~$350M, interest ~$190M, tax rate ~26%; emphasized non-residential strength amid market uncertainty.[1][2][3]"
      ],
      "catalysts": [
        "Q2 FY2026 earnings (expected ~March 2026): Potential margin beats and non-residential momentum could drive re-rating.[1][3]",
        "Non-residential project acceleration (e.g., public works, capital projects) and acquisition integration, leveraging underbuilt U.S. housing/infrastructure trends.[3][4]"
      ],
      "risk_factors": [
        "Persistent residential weakness from low housing starts, permit activity, and RMI slowdown, comprising ~50% of U.S. sales.[3][4]",
        "Macro uncertainty (e.g., economic slowdown, inflation) impacting construction; EPS miss reactions highlight sensitivity to guidance.[3][4]"
      ],
      "sources": [
        "https://www.moomoo.com/news/post/62629271/ferguson-enterprises-inc-ferg-q1-2026-earnings-call-transcript-summary",
        "https://quartr.com/companies/ferguson-enterprises-inc_3672",
        "https://www.investing.com/news/company-news/ferguson-q1-2026-slides-eps-miss-triggers-stock-decline-despite-revenue-beat-93CH-4398910",
        "https://www.youtube.com/watch?v=ZKruzocZHyc",
        "https://www.corporate.ferguson.com/investor/events-results-and-reports/default.aspx",
        "https://www.corporate.ferguson.com/pressroom/news-releases/news-details/2025/Ferguson-Reports-Quarter-Ended-October-31-2025/default.aspx",
        "https://www.corporate.ferguson.com/investor/why-ferguson/default.aspx",
        "https://www.marketbeat.com/stocks/NYSE/FERG/earnings/"
      ],
      "target_timeframe": "3-6 months"
    },
    {
      "ticker": "ENR",
      "name": "Siemens Energy AG",
      "exchange": "XETR",
      "index": "DAX",
      "sector": "Industrials",
      "price": 152.0,
      "currency": "EUR",
      "market_cap": 130012315648,
      "pe_ratio": 95.0,
      "forward_pe": 28.98324,
      "roe": 16.816,
      "dividend_yield": 46.0,
      "momentum_6m": 58.33333333333333,
      "momentum_12m": 166.19965685093595,
      "rsi_14": 71.95574684426185,
      "alpha_score": 70,
      "score_breakdown": {
        "value": 5,
        "quality": 22,
        "momentum": 23,
        "catalyst": 13,
        "liquidity": 7
      },
      "yahoo_url": "https://finance.yahoo.com/quote/ENR.DE",
      "signal": "BUY",
      "confidence": "HIGH",
      "reasoning": "**BULLISH** - **Confidence: HIGH**   Analyst upgrades and technical strength (trading above key SMAs with RSI near 72) signal sustained momentum from record orders and energy-transition demand, supporting targets up to \u20ac170.[1] Revenue growth of 13% recently and FY2026 guidance of 11-13% align with grid investment trends, justifying premium valuation despite high P/E.[1][2][4] Elevated expectations leave room for pullbacks, but fundamentals point to further upside over 3-6 months.[1]",
      "company_overview": "**  \nSiemens Energy AG is a Germany-based energy technology company supplying equipment and services for power generation, grids, and energy-transition projects, positioned at the intersection of structural demand for grid infrastructure and renewables. The stock has shown strong momentum, rising from \u20ac13.85 in early 2024 to around \u20ac143-152 recently, with 6-month returns of +58.3% and 12-month returns of +166.2%, driven by double-digit revenue growth, record order intake, and upgraded mid-term guidance through 2028.[1][2][3] Despite a high P/E of 95.0, ROE stands at 16.8%, reflecting improved fundamentals amid energy-transition tailwinds.[1]",
      "key_developments": [
        "Deutsche Bank raised its price target to \u20ac170 from \u20ac135 on January 29, 2026, citing stronger order pipeline, profitability, and grid/energy-transition demand; Jefferies followed on February 2, lifting to \u20ac164 with a buy rating on earnings visibility.[1]",
        "Shares gained 26% in the last month (as of early February 2026), pushing P/S to 3.4x above industry peers, with 13% recent revenue growth but forecasts matching industry at 12% annually.[2]",
        "CEO Christian Bruch addressed shareholders on February 3, 2026; company proposed \u20ac0.70 dividend for FY2025 and forecasts 11-13% comparable revenue growth with 9-11% profit margin for FY2026.[3][4][5]"
      ],
      "catalysts": [
        "FY2026 earnings and guidance updates, building on upgraded mid-term outlook through 2028 and proposed dividend payout.[1][4][5]",
        "Progress on order pipeline execution in grids and energy-transition projects amid supportive sector dynamics.[1]"
      ],
      "risk_factors": [
        "Elevated P/S ratio (3.4x vs. industry <1.7x) and revenue growth forecasts matching peers, risking correction if execution falters or macro sentiment shifts.[2]",
        "Persistent challenges in legacy onshore wind business and potential project delays in a high-expectation environment.[1]"
      ],
      "sources": [
        "https://capital.com/en-int/analysis/siemens-energy-stock-forecast",
        "https://simplywall.st/stocks/de/capital-goods/etr-enr/siemens-energy-shares/news/siemens-energy-ags-etrenr-26-price-boost-is-out-of-tune-with",
        "https://www.marketscreener.com/quote/stock/SIEMENS-ENERGY-AG-113080700/",
        "https://www.siemens-energy.com/global/en/home/investor-relations.html",
        "https://www.perplexity.ai/finance/ENR.DE"
      ],
      "target_timeframe": "3-6 months"
    },
    {
      "ticker": "SAF",
      "name": "Safran SA",
      "exchange": "EPA",
      "index": "CAC40",
      "sector": "Industrials",
      "price": 308.0,
      "currency": "EUR",
      "market_cap": 128284680192,
      "pe_ratio": 29.758453,
      "forward_pe": 29.628347,
      "roe": 34.745997,
      "dividend_yield": 94.0,
      "momentum_6m": 5.987609611503686,
      "momentum_12m": 26.409959646058656,
      "rsi_14": 39.782594994443805,
      "alpha_score": 70,
      "score_breakdown": {
        "value": 5,
        "quality": 25,
        "momentum": 20,
        "catalyst": 13,
        "liquidity": 7
      },
      "yahoo_url": "https://finance.yahoo.com/quote/SAF.PA",
      "signal": "BUY",
      "confidence": "MEDIUM",
      "reasoning": "Safran's dominant position in commercial aero engines supports sustained growth amid global air travel recovery, evidenced by strong historical returns (+45.52% yearly) and superior ROE (27.93-34.7%) versus peers like RTX and GE.[1][2] However, elevated valuations (P/E 29.8-38.74, trading premium to fair value) and short-term forecasts suggest potential pullback, balancing quality/momentum strengths (Alpha Score 70/100) against value weakness.[1][2] Medium confidence reflects solid fundamentals but limited recent catalysts.",
      "company_overview": "Safran SA is a leading French aerospace and defense company specializing in aircraft engines, propulsion systems, and equipment, with a strong market position as a key supplier to Airbus and Boeing. It reports robust financials including \u20ac7.85B in sales revenues, \u20ac5.05B net income, and a market cap of \u20ac126.23B, underpinned by high ROE of ~28-35% and recent stock performance showing +45.52% yearly gains as of late October 2025.[1][2] Shares recently traded around \u20ac305-308, hitting all-time highs in late 2025 amid positive momentum, though trading at a 546% premium to Morningstar's \u20ac391 fair value with medium uncertainty.[1][2][4]",
      "key_developments": [
        "Shares reached multiple all-time highs in Q4 2025 (e.g., \u20ac305.80 on Oct 3, \u20ac298.80 on Sep 30), with 4-week gains of up to 8.83% and 12-month rise of 46.97%, reflecting strong aerospace demand.[1]",
        "Recent trading (early Feb 2026) showed volatility around \u20ac300-305, with a dip to \u20ac298.25 (lowest since Jan 2026) but recovery to \u20ac308 (+1.82% on Feb 6), and 4-week gain of 0.71-3.21%.[1][3][4]",
        "No major company-specific news in the last 30 days (early Jan to Feb 7, 2026); price action driven by broader market trends and analyst forecasts projecting Q4 at \u20ac296.34 and 1-year at \u20ac273.15.[1][3]"
      ],
      "catalysts": [
        "Q4 2025 earnings release and full-year guidance (expected soon post-Feb 2026), potentially confirming revenue/EBITDA beats given recent highs.[1][5]",
        "Aerospace sector tailwinds from Airbus A320neo/ Boeing 737 MAX production ramps, boosting engine aftermarket services.[2]"
      ],
      "risk_factors": [
        "Valuation stretch (P/E 38.74 normalized, 546% above fair value) vulnerable to downward revisions if growth slows, with 1-year forecast at \u20ac273.15 (-11% from current).[1][2]",
        "Macro pressures like supply chain disruptions in industrials or geopolitical tensions impacting defense/aero demand, plus recent price volatility (e.g., Feb dips).[1][3]"
      ],
      "sources": [
        "https://tradingeconomics.com/saf:fp",
        "https://www.morningstar.com/stocks/xpar/saf/quote",
        "https://www.investing.com/equities/safran-historical-data",
        "https://www.safran-group.com/finance/safran-share-price",
        "https://www.safran-group.com/finance/glance",
        "https://finbox.com/ENXTPA:SAF/"
      ],
      "target_timeframe": "3-6 months"
    },
    {
      "ticker": "GSK",
      "name": "GSK plc",
      "exchange": "LSE",
      "index": "FTSE100",
      "sector": "Healthcare",
      "price": 2198.0,
      "currency": "GBP",
      "market_cap": 88211988480,
      "pe_ratio": 15.812949,
      "forward_pe": 11.246936,
      "roe": 43.310001,
      "dividend_yield": 328.0,
      "momentum_6m": 56.58391015225654,
      "momentum_12m": 50.04716990172777,
      "rsi_14": 85.63432835820896,
      "alpha_score": 70,
      "score_breakdown": {
        "value": 13,
        "quality": 19,
        "momentum": 23,
        "catalyst": 5,
        "liquidity": 10
      },
      "yahoo_url": "https://finance.yahoo.com/quote/GSK.L",
      "signal": "BUY",
      "confidence": "HIGH",
      "reasoning": "GSK's strong 2025 execution, guided 2026 growth in core profitability outpacing sales, and long-term \u00a340 billion sales target support re-rating potential, especially with robust Specialty Medicines momentum and dividend hike amid a 26-year share price high.[1][3][5][7] However, moderating sales growth guidance and looming patent losses temper upside, with RSI near 70 signaling overbought conditions in a volatile global pharma context.[2][5] At P/E 15.8 and Alpha Score 70/100, the stock offers value with momentum, but execution risks warrant caution over 3-6 months.[2]",
      "company_overview": "GSK plc is a leading global healthcare company focused on pharmaceuticals, vaccines, and specialty medicines, with strong 2025 performance including 4% turnover growth to \u00a332.7 billion, core operating profit up 11%, and core EPS up 12%.[1][3][6] The company holds a robust market position driven by double-digit growth in Specialty Medicines (Respiratory, Immunology & Inflammation, Oncology, and HIV), alongside reaffirmed long-term sales outlook exceeding \u00a340 billion by 2031.[1][3][5] Shares recently hit a 26-year high near \u00a320-\u00a321, reflecting a 6.91% surge post-Q4 results and +56.6% 6-month return, supported by high ROE of 43.3%.[5][7]",
      "key_developments": [
        "Reported strong Q4 and FY 2025 results on February 4, 2026, with Q4 turnover up 6-8% to \u00a38.6 billion, core operating profit up 14-18%, and profit before tax doubling to \u00a3950 million; full-year core EPS reached 172p, up 12%.[1][3][4][6]",
        "Issued 2026 guidance projecting turnover growth of 3-5%, core operating profit and EPS growth of 7-9% at constant exchange rates, with increased full-year dividend to 70p per share from 66p.[1][2][3][5]",
        "Announced positive Phase III trial results in January 2026 for B-Well 1 and B-Well 2, alongside new CEO Luke Miels emphasizing momentum in commercial launches and R&D in Oncology and Vaccines.[1][5][6]"
      ],
      "catalysts": [
        "Commercial launches and R&D progression in Oncology, Vaccines, and HIV, building on 2026 guidance execution under new CEO.[1][6]",
        "Potential positive readouts from ongoing pipeline, including January 2026 Phase III successes, driving Specialty Medicines low double-digit growth.[1][3][6]"
      ],
      "risk_factors": [
        "Slower 2026 sales growth (3-5%) due to vaccine/general medicines declines and HIV patent losses from 2028, amid U.S. tariff uncertainties under Trump policy.[2][5]",
        "Regulatory pressures, competitive dynamics in pharma, moderate leverage (debt-to-equity 1.1), and Altman Z-Score of 2.13 indicating some financial stress.[2]"
      ],
      "sources": [
        "https://www.nasdaq.com/articles/gsk-q4-results-climb-sees-growth-fy26-backs-2031-sales-view-update",
        "https://www.gurufocus.com/news/8580044/gsk-projects-moderate-growth-in-turnover-and-earnings-by-2026",
        "https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-strong-2025-performance-and-re-affirms-long-term-outlooks/",
        "https://www.ig.com/uk/news-and-trade-ideas/gsk-full-year-earnings--can-the-pharma-giant-deliver-on-post-dem-260203",
        "https://www.voxmarkets.com/articles/gsk-sees-slower-sales-growth-in-2026-as-patent-loss-looms-7c4f7f2",
        "https://www.gsk.com/media/g0lnid23/fy-2025-results-announcement.pdf",
        "https://kalkine.co.uk/news/premium/gsk-plc-at-a-26-year-high-is-the-market-re-rating-the-stock"
      ],
      "target_timeframe": "3-6 months"
    },
    {
      "ticker": "RIO",
      "name": "Rio Tinto Group",
      "exchange": "LSE",
      "index": "FTSE100",
      "sector": "Basic Materials",
      "price": 6843.0,
      "currency": "GBP",
      "market_cap": 111193030656,
      "pe_ratio": 14.716128,
      "forward_pe": 12.113603,
      "roe": 17.158002,
      "dividend_yield": 416.0,
      "momentum_6m": 49.673994048695945,
      "momentum_12m": 36.53139134072427,
      "rsi_14": 66.68874172185431,
      "alpha_score": 70,
      "score_breakdown": {
        "value": 13,
        "quality": 22,
        "momentum": 25,
        "catalyst": 0,
        "liquidity": 10
      },
      "yahoo_url": "https://finance.yahoo.com/quote/RIO.L",
      "signal": "BUY",
      "confidence": "HIGH",
      "reasoning": "Rio Tinto's pivot to high-growth copper and lithium (via Arcadium acquisition) alongside iron ore supports mid-term production expansion, with strong balance sheet (debt-to-equity 0.41) and cash generation offsetting commodity volatility.[1][2] Valuation at P/E 14.7x remains attractive vs. industry average (23.28x), backed by project execution like Oyu Tolgoi and Simandou, though near-term overbought signals warrant caution.[1][3] Analyst moderate buy rating (2.1 score) aligns with 44.7% 1-year returns and projected FCF growth to $13.6B by 2030.[1][3]",
      "company_overview": "Rio Tinto Group is a leading global mining company with major assets in iron ore (Pilbara operations), copper (Escondida and Oyu Tolgoi mines), and aluminium, maintaining a strong market position in the Basic Materials sector with a $151.14 billion market cap.[1] Despite a 3-year revenue growth decline of -3.9%, it exhibits robust financial health, including a 25.39% operating margin, 19.2% net margin, current ratio of 1.53, and Altman Z-Score of 3.67.[1] Shares have delivered strong returns (6m: +49.7%, 12m: +36.5%), trading at a P/E of 14.7 near 3-year highs, with recent resilience shown in H1 2025 Underlying EBITDA of $11.5 billion amid iron ore price headwinds.[1][2]",
      "key_developments": [
        "Declined merger offer from Glencore, prioritizing independence, leadership roles (Chair and CEO), and valuation, especially in copper; Glencore cited misalignment with shareholder interests.[1][4]",
        "H1 2025 results showed resilient EBITDA ($11.5B, -5% YoY) and cash flow ($6.9B, -2% YoY) despite 13% iron ore price drop, offset by aluminium (+50% EBITDA) and copper (+69% EBITDA) growth; capex rose 18% to $4.7B for projects like Oyu Tolgoi ramp-up.[2]",
        "Accelerated Simandou iron ore project in Guinea, targeting first shipment by November 2025; shares recently up 11.6% over 30 days to \u00a366.76, with RSI at 71.35 indicating overbought conditions.[1][2][3]"
      ],
      "catalysts": [
        "2025 Annual Results release on 19 February 2026, potentially highlighting full-year performance and project updates.[5]",
        "Simandou iron ore first shipment around November 2025 and Oyu Tolgoi copper ramp-up, driving production growth.[2]",
        "2026 Final dividend ex-date, maintaining 50% payout policy amid $2.4B interim dividend.[2][6]"
      ],
      "risk_factors": [
        "Commodity price fluctuations, particularly iron ore (13% H1 2025 decline), impacting revenue amid diversification efforts.[1][2]",
        "Elevated valuation near 3-year P/E and P/S highs, with overbought RSI (71.35) and recent profit-taking post-merger news.[1][3][4]",
        "Regulatory and operational risks in multi-jurisdictional projects (e.g., Simandou in Guinea, Oyu Tolgoi in Mongolia).[1][2]"
      ],
      "sources": [
        "https://www.gurufocus.com/news/8586961/rio-tinto-rio-declines-offer-maintaining-independence",
        "https://www.tikr.com/blog/can-rio-tintos-aggressive-pivot-to-lithium-and-copper-projects-sustain-growth-in-2026",
        "https://simplywall.st/stocks/gb/materials/lse-rio/rio-tinto-group-shares/news/has-the-market-fully-reflected-rio-tinto-lserios-strong-rece",
        "https://www.morningstar.com/news/marketwatch/2026020614/whats-next-for-rio-tinto-and-glencore-after-260-billion-megamerger-aborted",
        "https://www.riotinto.com/en/invest/financial-news-performance",
        "https://www.riotinto.com/en/invest/financial-calendar",
        "https://www.riotinto.com/en/invest/reports"
      ],
      "target_timeframe": "3-6 months"
    },
    {
      "ticker": "AMAT",
      "name": "Applied Materials, Inc.",
      "exchange": "US",
      "index": "NASDAQ_SELECT",
      "sector": "Technology",
      "price": 322.51,
      "currency": "USD",
      "market_cap": 255983124480,
      "pe_ratio": 37.15553,
      "forward_pe": 26.492924,
      "roe": 35.508,
      "dividend_yield": 56.99999999999999,
      "momentum_6m": 75.29524861161806,
      "momentum_12m": null,
      "rsi_14": 48.28819156800613,
      "alpha_score": 70,
      "score_breakdown": {
        "value": 5,
        "quality": 25,
        "momentum": 17,
        "catalyst": 13,
        "liquidity": 10
      },
      "yahoo_url": "https://finance.yahoo.com/quote/AMAT",
      "signal": "BUY",
      "confidence": "HIGH",
      "reasoning": "AMAT benefits from robust AI-driven demand for chipmaking equipment, recurring revenue from services/upgrades, and strong analyst support with targets well above current price (~$322).[1][2][4] Recent earnings beats, 66% AI-tied gains, and \"wide-moat\" model provide resilience amid sector volatility, positioning it for outperformance vs. semis peers.[1][2] FY2026 consensus projects +1.27% EPS growth to $9.54 despite near-term YoY declines.[3][5]",
      "company_overview": "Applied Materials, Inc. (AMAT) is a leading provider of semiconductor manufacturing equipment, materials engineering solutions, and services, holding a strong position in advanced chipmaking tools critical for AI, data centers, EVs, and automation.[1][2][4] The company recently beat Q4 FY2025 EPS ($2.17 vs. $2.11 expected) and revenue ($6.80B vs. $6.68B), with ROE at 39.26% and a market cap near $256B, though quarterly revenue dipped 3.5% YoY.[1] Shares surged 6.1% to $322.51 on February 6, 2026, amid high volume ($2.64B-$8.2M shares), reflecting AI-driven momentum despite a recent -2.96% drop to $318.67.[1][2][5]",
      "key_developments": [
        "Shares jumped 6.1% on Feb 6, 2026, to $322.51 (intraday high $324.40), leading chip-equipment sector amid AI demand and $2.64B volume, ranking 34th in daily activity.[1][2]",
        "Analyst upgrades: Deutsche Bank to Buy/$390 (Jan 23), KeyCorp to $380 (Jan 16), Morgan Stanley to $364, Citi to $400; consensus \"Moderate Buy\" with $315.15 avg target (24 Buys, 8 Holds).[1][2]",
        "Recent stock volatility: -2.96% drop to $318.67 in prior session; Q1 FY2026 guidance $1.98\u2013$2.38 EPS, $0.46 dividend (yield ~0.6%).[1][5]"
      ],
      "catalysts": [
        "Q1 FY2026 earnings on Feb 12, 2026: Expected $2.19 EPS/$6.89B revenue; beat could drive upside given history and AI momentum.[3][5]",
        "AI capex ramps from chipmakers (e.g., TSMC) and advanced packaging demand, boosting orders.[2][4]"
      ],
      "risk_factors": [
        "Year-over-year earnings/revenue declines expected in Q1 (-8% EPS, -3.9% revenue); miss could pressure stock.[3][5]",
        "U.S.-China export restrictions on high-end tools, risking $600M revenue and shipment delays.[2][4]"
      ],
      "sources": [
        "https://www.marketbeat.com/instant-alerts/applied-materials-nasdaqamat-trading-up-61-whats-next-2026-02-06/",
        "https://www.ainvest.com/news/applied-materials-surges-6-1-ai-driven-demand-ranks-34th-2-64-billion-trading-volume-2602/",
        "https://www.nasdaq.com/articles/applied-materials-amat-expected-beat-earnings-estimates-can-stock-move-higher",
        "https://simplywall.st/stocks/us/semiconductors/nasdaq-amat/applied-materials/news/applied-materials-balances-ai-growth-opportunity-with-new-ch",
        "https://www.zacks.com/stock/news/2828386/heres-why-applied-materials-amat-fell-more-than-broader-market",
        "https://www.tipranks.com/news/applied-materials-stock-amat-plunges-despite-hopes-for-a-more-constructive-direction"
      ],
      "target_timeframe": "3-6 months"
    },
    {
      "ticker": "DHL",
      "name": "Deutsche Post AG",
      "exchange": "XETR",
      "index": "DAX",
      "sector": "Industrials",
      "price": 49.7,
      "currency": "EUR",
      "market_cap": 57314856960,
      "pe_ratio": 16.188925,
      "forward_pe": 15.037458,
      "roe": 16.792,
      "dividend_yield": 372.0,
      "momentum_6m": 21.72421879525457,
      "momentum_12m": 48.088536973267004,
      "rsi_14": 73.08786675989094,
      "alpha_score": 69,
      "score_breakdown": {
        "value": 18,
        "quality": 16,
        "momentum": 23,
        "catalyst": 5,
        "liquidity": 7
      },
      "yahoo_url": "https://finance.yahoo.com/quote/DHL.DE",
      "signal": "BUY",
      "confidence": "HIGH",
      "reasoning": "Deutsche Post AG (DHL) is the global market leader in logistics, operating across express delivery, freight forwarding, supply chain solutions, and domestic parcel/mail services[5]. The company has demonstrated consistent earnings growth through 2025, with Q3 EBIT increasing 7.6% to EUR 1.5 billion despite revenue headwinds from currency effects and U.S. trade tensions[2]. DHL's strong operational performance and cash generation have positioned it favorably within the industrials sector, with consensus forecasts showing net profit growth from EUR 3.5 billion (2025E) to EUR 4.4 billion (2027E)[3].",
      "company_overview": "Deutsche Post AG (DHL) is the global market leader in logistics, operating across express delivery, freight forwarding, supply chain solutions, and domestic parcel/mail services[5]. The company has demonstrated consistent earnings growth through 2025, with Q3 EBIT increasing 7.6% to EUR 1.5 billion despite revenue headwinds from currency effects and U.S. trade tensions[2]. DHL's strong operational performance and cash generation have positioned it favorably within the industrials sector, with consensus forecasts showing net profit growth from EUR 3.5 billion (2025E) to EUR 4.4 billion (2027E)[3].",
      "key_developments": [
        "**Q3 2025 earnings beat**: EBIT margin expanded to 7.3% (Q3 2024: 6.7%), marking four consecutive quarters of earnings growth despite a 2.3% revenue decline driven by currency headwinds and lower U.S. volumes[2]"
      ],
      "catalysts": [
        "**2025 full-year results (March 2026)**: Confirmation of EUR 6 billion+ EBIT guidance and EUR 3 billion free cash flow target would validate earnings momentum[2]"
      ],
      "risk_factors": [
        "**Global Forwarding deterioration**: EBIT margin compression to 4.3% in Q3 2025 (down from 5.5% year-ago) reflects structural challenges in road freight; further economic weakness could accelerate declines[2]"
      ],
      "sources": [
        "https://group.dhl.com/en/media-relations/press-releases/2025/dhl-group-financial-figures-q1-2025.html",
        "https://group.dhl.com/en/media-relations/press-releases/2025/dhl-group-financial-figures-q3-2025.html",
        "https://group.dhl.com/en/investors/shares/consensus.html",
        "https://reporting-hub.group.dhl.com/2025-q3/en/business-performance/",
        "https://group.dhl.com/en/investors.html",
        "https://www.marketscreener.com/news/dhl-consensus-full-year-dhl-consensus-fy-2026-2-2-ce7e5bd2d989fe2c",
        "https://israelgives.org/celebs-details/282/How-Deutsche-Post-AG-(DHL)-stock-performs-during-market-turbulence",
        "https://simplywall.st/stocks/bg/transportation/bul-dhl/deutsche-post-shares/past"
      ],
      "target_timeframe": "3-6 months"
    }
  ]
}